Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
67.96
-0.21 (-0.31%)
Mar 13, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.89 billion as of March 13, 2026. Its market cap has increased by 73.05% in one year.
Market Cap
2.89B
Enterprise Value
2.56B
1-Year Change
73.05%
Ranking
Category
Stock Price
$67.96
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.89B, an increase of 838.59%. That is a compound annual growth rate of 51.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 2.89B | -16.79% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 3.17B |
| Spyre Therapeutics | 3.13B |
| Dyne Therapeutics | 2.96B |
| Viridian Therapeutics | 2.93B |
| IDEAYA Biosciences | 2.91B |
| Vera Therapeutics | 2.85B |
| Catalyst Pharmaceuticals | 2.84B |
| Arcutis Biotherapeutics | 2.82B |